Merck KGaA (FRA:MRK)

Market Cap	59.52B +13.3%
Revenue (ttm)	21.14B -0.4%
Net Income	2.37B -17.2%
EPS	5.45 -17.3%
Shares Out	n/a
PE Ratio	25.11
Forward PE	15.83
Dividend	2.20 (1.62%)
Ex-Dividend Date	Apr 27, 2026

Volume	n/a
Open	137.45
Previous Close	136.45
Day's Range	135.60 - 137.45
52-Week Range	100.65 - 147.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 62,136
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MRK

Financial Performance

In 2025, Merck KGaA's revenue was 21.10 billion, a decrease of -0.26% compared to the previous year's 21.16 billion. Earnings were 2.61 billion, a decrease of -6.09%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 5, 2026

Data Sources Report a data error